Sarepta Therapeutics (SRPT) PT Raised to $96 at Nomura/Instinet on 4Q Beat; 'Pipeline Registration Path & DMD Gene Therapies Emerge in 2018'

Go back to Sarepta Therapeutics (SRPT) PT Raised to $96 at Nomura/Instinet on 4Q Beat; 'Pipeline Registration Path & DMD Gene Therapies Emerge in 2018'
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 22.50 -0.49 (2.13%)
Previous Close $22.99    52 Week High $63.73 
Open $22.58    52 Week Low $8.00 
Day High $22.65    P/E N/A 
Day Low $21.98    EPS $-5.69 
Volume 2,955,534